Concepedia
Statistics
Publications
3
Citations
54
H-Index
Active since
2018
Affiliations
University of Chicago(Current)
Asan Medical Center
Merck & Co., Inc., Rahway, NJ, USA (United States)
T. Kim is an author at University of Chicago specializing in oncology, pharmacology, and metastatic disease management.
Publications per year
2018–2023
LBA-5 Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer (mCRC): the phase 3 LEAP-017 study
Akihito Kawazoe, Rui‐Hua Xu, Maria Passhak et al. · Annals of Oncology · 2023 · 27 citations · Full text
Medicine, Oncology, Pharmacology +10
Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability–high (MSI-H) colorectal cancer: KEYNOTE-164
Dung T. Le, Petr Kavan, T. Kim et al. · Annals of Oncology · 2018 · 16 citations · Full text
Medicine, Oncology, Pharmacology +15
Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer
Nahee Hwang, Bo Kyung Yoon, Kyu-Hye Chun et al. · Experimental & Molecular Medicine · 2023 · 11 citations · Full text
Medicine, Cell Biology, Oncology +15
1–3 of 3